- Apheresis is a procedure that lets you draw blood and separate its components like platelets, leukocytes, and plasma for medical uses. The apheresis equipment market size is projected to attain revenue worth USD 2.8 billion by 2020, as per a report by Grand View Research, Inc. It is expected a significant growth rate of over 11% from 2014 to 2020. The number of rising blood disorders like cancer, sickle cell anemia, and hemophilia. Cholesterol is a common lifestyle disease that needs apheresis equipment for its treatment.
For Market Research Report on “Apheresis Equipment Market” Visit -http://www.grandviewresearch.com/industry-analysis/apheresis-equipment-market
The apheresis equipment market is divided on the basis of products, applications, procedures, technology, and regions. Devices and disposables are products currently offered by the market. Apheresis devices were the dominant product out of the two, on account of its pricing. But apheresis disposables had a 14% CAGR over the forecast phase. Initiatives to prevent hospital acquired infections or bloodstream infection will boost the apheresis equipment market demand.
The applications include hematology, renal disease, neurology, and other diseases. Neurology had more than half of the market’s share in 2013 due to rise of blood disorders like multiple sclerosis.
Plasmapheresis, leukapheresis, plasmapheresis, plateletpheresis, erythrocytapheresis, LDL-apheresis, and photopheresis are the different procedures in which the apheresis equipments are used. Plasmapheresis had the largest share in 2013 and was valued to be worth USD 746.8 million. Photopheresis has the largest scope for growth with an estimated 13.4% growth rate over the next 6 years. This will due to the presence of Sézary syndrome.
Membrane filtration and centrifugation are the two technology segments. Membrane filtration was the dominant technology of the two and valued at over USD 800 million in 2013. Centrifugation is not limited to plasma exchange as membrane filtration. It has a 12.6% growth rate over the forecast phase.
North America accounted for more than 48% of the global revenue in 2013 on account of increased health expenditure and improved infrastructure. Asia Pacific has a 13.5% CAGR during the forecast phase on account of the rising economies of India and China.
The global players of the apheresis equipment market are Terumo BCT, Inc., Cerus Corporation, Haemonetics Corporation, B Braun Melsungen AB, and Kaneka Corporation. The establishment of blood banks, blood donation camps and easy access to healthcare can catapult the market’s growth.
Information Source: Grand View Research
To request a sample copy of this report, please complete the form below.
To purchase a copy of this report, please contact at
28 2nd Street, Suite 3036
San Francisco, CA 94105
Toll Free: 1-888-202-9519